2018
DOI: 10.1016/j.physbeh.2018.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 64 publications
1
9
1
Order By: Relevance
“…After the mice became stationary, the body weight was recorded from the digital display of the weighing scale once it had stabilized. Body weight was measured for up to six days after the third reserpine injection (n = 6) [31].…”
Section: Body Weightmentioning
confidence: 99%
See 1 more Smart Citation
“…After the mice became stationary, the body weight was recorded from the digital display of the weighing scale once it had stabilized. Body weight was measured for up to six days after the third reserpine injection (n = 6) [31].…”
Section: Body Weightmentioning
confidence: 99%
“…The temperature-sensitive probe was connected to equipment that indicated a digital temperature scale. Rectal temperatures were taken for six days after inducing FM in the model mice (n = 6) [31].…”
Section: Rectal Temperaturementioning
confidence: 99%
“…A previous study reported that the metabolites of serotonin, dopamine, and noradrenaline in the cerebrospinal fluid (CSF) were lower in patients with FM, suggesting that catecholamine levels may be lower in the brain (47). Consistently, the animal model of FM with repeated reserpine administration replicated human FM symptoms and displayed decreases in catecholamines in the brain and spinal cord (29,34,35,48,49). The present study also replicated characteristic symptoms of human patients with FM and the animal model of FM reported in previous studies.…”
Section: Reproduction Of the Fm Modelmentioning
confidence: 74%
“…First, patients with FM often present with eating disorders and/or bodyweight loss (50,51). Previous animal studies also reported that the FM mouse model displayed the lowest bodyweight 3 days after the first injection (31,48). After the reserpine administration, access to food was reduced, eating time was extended, and food intake was sharply reduced (52).…”
Section: Reproduction Of the Fm Modelmentioning
confidence: 99%
“…In the case of mice, there is a range of protocols used. Reserpine is preferably administered subcutaneously 12 at 0.25 (de Souza et al, 2014;Peres Klein et al, 2016;Nagakura et al, 2018), 0.5 (Kaur et al, 2021;Schossler Garcia et al, 2021a), or 1 mg/kg (Xu et al, 2013;Liu et al, 2014;Brum et al, 2020) once daily for three consecutive days. Intraperitoneal administration at 0.5 mg/kg once daily for three consecutive days is also employed (Sousa et al, 2018).…”
Section: Protocol For Rim-induced Nociplastic Pain-associated Phenotypesmentioning
confidence: 99%